]>
IRCT20210315050707N1 IRCT 2021-06-01 Tabriz University of Medical Sciences Investigation the effect of the " Prunus Dulcis Linctus" on treatment of cough Investigation the effect of the " Prunus Dulcis Linctus" on asthmatic Patients ( refractory with chronic cough) 2021-04-21 anticipated 100 Complete https://irct.ir/trial/55021 interventional Randomization: Not randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: This study was conducted as a single_blind. Given that the appearance of the medicinal substance containing Prunus Dulcis Linctus extract is the same as that of Placebo medicinal substance, Patient werw not informed about the nature of them and they didn't know whether thay were the main drug or Placebo. 3 Asthma. Intervention 1: Intervention group: the intervention group including fifty people, whose admission requirements has been confirmed according to determined criteria, was treated with 15 g of the Prunus Dulcis Linctus ( 5 g in the morning , 5 g in the midday and 5 g at night) for 14 days. Prunus Dulcis Linctus under study made by Andishe teb booali company,Iran . Intervention 2: Control group: including fifty people who their clinical features are the same as the intervention group. They received placebo instead of interventional as the same procedure as the intervention group. Placebo under study made by Andishe teb booali company, Iran . No - There is not a plan to make this available Justification or reason for not sharing IPD is There is not more Data for sharing.
public Maryam Seyyedi
No.34, Nasiri str, Sahand.
Tabriz Iran (Islamic Republic of) 5331775666 +98 41 3361 9279 maryamsiedy@yahoo.com Tabriz University of Medical Sciences scientific Maryam Seyyedi
No.34, Nasiri str, Sahand.
Tabriz Iran (Islamic Republic of) 5331775666 +98 41 3361 9279 maryamsiedy@yahoo.com Tabriz University of Medical Sciences Iran (Islamic Republic of) Patients with asthma whose cough has not been treated with common medications. Patients over 14 years Patients who have signed the consent form. 14 years no limit Both Patients with Kidney failure and Diabetes Patients who were unavailable for follow-up J45 Asthma Treatment - Drugs Placebo Intervention group: the intervention group including fifty people, whose admission requirements has been confirmed according to determined criteria, was treated with 15 g of the Prunus Dulcis Linctus ( 5 g in the morning , 5 g in the midday and 5 g at night) for 14 days. Prunus Dulcis Linctus under study made by Andishe teb booali company,Iran . Control group: including fifty people who their clinical features are the same as the intervention group. They received placebo instead of interventional as the same procedure as the intervention group. Placebo under study made by Andishe teb booali company, Iran . Refractory Asthma. Timepoint: Comparison of Spirometry values as well as patient history before and two weeks after the "Prunus Dulcis Linctus" consumption. Method of measurement: Spirometry test - Cough Questionnaire. Tabriz University of Medical Sciences Approved 2021-05-17 Ethics committee of Tabriz University of Medical Sciences Tabriz University of Medical Sciences, Tuberculosis and Lung Diseases Research Center Tabriz East Azarbaijan Iran (Islamic Republic of)